Serum Institute may double production of AstraZeneca-Oxford vaccine in 2022

Expect 200-million AstraZeneca vaccine doses next year

Serum Institute of India (SII) is likely to double the production of the AstraZeneca-Oxford vaccine from 100 million per month now to 200 million per month next year, said people in the know.

Pune-based SII, the world’s largest vaccine maker, now has the capacity to make about 3 billion vaccine doses, Covid and non-Covid, a year. By the end of 2022, this could be scaled up to over 4 billion annual doses.

Speaking at a recent event, Nadhim Zahawi, minister in charge of the UK’s Covid-19 vaccine deployment, said SII would be scaling up its AstraZeneca-Oxford vaccine manufacturing capacity to 200 million